With more than 30 years of executive leadership and Board service experience, Mr. Berardino has a proven track record of managing complex Board and C-Suite dynamics to enact change. Throughout his career, he served in various capacities, from CEO to Chairman of the Board for Profectus Bio Sciences. In addition, Mr. Berardino frequently lectures on corporate governance, leadership and ethics before senior corporate executives and college campuses.
At A&M, Mr. Berardino brings a differentiated transformation offering to corporations that desire change at a pace and scale that traditional approaches cannot match. He leverages the functional expertise offered by performance improvement talent coupled with the firm’s renowned restructuring and private equity capabilities to help businesses that are vulnerable or looking to keep pace with constant disruptors address activist investors and position their corporation for success through enterprise-wide change.
Prior to joining A&M, Mr. Berardino was an audit partner with Arthur Andersen, where he spent 30+ years in various client-serving and leadership roles, including CEO of Andersen Worldwide.
Mr. Berardino earned a bachelor's degree in accounting from Fairfield University. He is currently a member of the Board of Advisors for the University of Maryland School of Medicine’s Institute of Human Virology and has served on several public company Boards of Directors. For Fairfield University, Mr. Berardino served as a member of the Board of Trustees for 18 years and has chaired the Advancement and Finance Committees.